Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C91383
http://purl.obolibrary.org/obo/NCIT_C91383
|
|---|---|
| Preferred Name | Anti-GD2 Monoclonal Antibody MORAb-028 |
| Definitions |
A human IgM monoclonal antibody directed against disialoganglioside GD2 with potential immunomodulating activity. Upon administration, anti-GD2 monoclonal antibody MORAb-028 may stimulate the immune system to exert a complement-mediated cytotoxic response against GD2-expressing tumor cells. The glycosphingolipid GD2 is a tumor associated antigen (TAA) overexpressed on the surface of many cancer cells.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A human IgM monoclonal antibody directed against disialoganglioside GD2 with potential immunomodulating activity. Upon administration, anti-GD2 monoclonal antibody MORAb-028 may stimulate the immune system to exert a complement-mediated cytotoxic response against GD2-expressing tumor cells. The glycosphingolipid GD2 is a tumor associated antigen (TAA) overexpressed on the surface of many cancer cells. |
|---|---|
| prefLabel | Anti-GD2 Monoclonal Antibody MORAb-028
|
| label | Anti-GD2 Monoclonal Antibody MORAb-028
|
| NCI_META_CUI | CL421587
|
| PDQ_Closed_Trial_Search_ID | 673996
|
| code | C91383
|
| prefixIRI | NCIT:C91383
|
| in_subset | |
| Preferred_Name | Anti-GD2 Monoclonal Antibody MORAb-028
|
| Maps_To | Anti-GD2 Monoclonal Antibody MORAb-028
|
| NCI_Drug_Dictionary_ID | 673996
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 673996
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |